Akebia Therapeutics, Inc. To Participate In Upcoming Investor Conferences
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will participate in two upcoming investor conferences:
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.